New way treat the Crohn's Disease in the time to come

Two recent studies have clearly shown that a new drug called Cimzia may ease symptoms of Crohn's disease. The two new studies, published in The New England Journal of Medicine, highlight Cimzia's clinical trials in Crohn's disease patients.

It is said that Patients would give themselves injections of the drug, which targets an inflammatory chemical called tumor necrosis factor (TNF) alpha. In the tests conducted, patients taking Cimzia were more likely to maintain their improvement in Crohn's symptoms during the six-month study, compared with those taking the placebo.

Both the recent studies were completely funded by the UCB Pharma, which is the manufacturer of Cimzia. Both of the sets of researchers note financial ties to various drug companies, including UCB Pharma.